L. Iddon et al. / Tetrahedron 65 (2009) 6396–6402
6401
CHCH2Nþ), 4.39 (1H, d, J¼8.9 Hz, 1-H), 5.62 (1H, dd, J¼10.0 and
1.5 Hz, CH]CH2 cis-olefinic H), 5.66 (1H, dd, J¼17.2 and 1.5 Hz,
The reactants were stirred at rt for 24 h: the DCM was then re-
moved in vacuo. Column chromatography was carried out using
EtOAc to afford the product 21 (49%) as a solid, mp 91–92 ꢀC. Found:
m/z, 668.3407. C44H46NO5 (MHþ) requires m/z, 668.3376; 1H NMR:
CH]CH2 trans-olefinic H), and 5.90–6.00 (1H, m, CH2CH]CH2); 13
C
NMR:
d [(CD3)2SO] 47.1, 48.3, 60.5, 65.9, 68.9, 70.1, 76.9, 80.1, 93.3,
125.4 and 129.0; m/z (ES þve mode) 248 (cation Mþ, 100%).
d (CD3CN) 2.40–2.47 (2H, m, ]CHCH2), 2.40 (3H, s, NCH3), 2.90–
3.00 (2H, m, NCH2CH2), 2.95–3.15 (4H, br m, ArCH2CH2Ar), 3.18 (1H,
dd, J¼10.0 and 5.5 Hz, 6a-H), 3.25–3.32 (3H, m, 4-Hþ5-Hþ6b-H),
3.33 (1H, t, J¼9 Hz, 3-H), 3.40 (1H, t, J¼8.5 Hz, 2-H), 3.91 (1H, d,
J¼8.8 Hz, 1-H), 5.92 (1H, t, J¼7.6 Hz, ]CHCH2), 7.05–7.33 (17H, m,
4.5. N-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-
piperidine (16)
This was prepared essentially according to the reported pro-
cedure, Ref. 26 in the text as a white solid. Found: C, 55.1; H, 7.1; N,
3.2; m/z, 438.1718. C19H29NO9 requires C, 54.9; H, 7.0; N, 3.4%;
ArH) and 7.49–7.53 (6H, m, ArH); 13C NMR:
d (CD3CN) 27.6, 31.2,
33.0, 34.3, 53.3, 63.4, 69.5, 70.1, 76.1, 77.4, 85.7, 93.6, 125.4, 125.5,
126.7, 126.8, 127.1,127.4, 127.6, 127.7,128.0, 128.3, 129.0, 129.7, 136.6,
139.1, 139.8, 140.8, 143.1 and144.0; m/z (ES þve mode) 668 (MHþ,
100%).
C19H29NO9Na requires m/z, 438.1740; 1H NMR:
d (CDCl3) 1.40–1.55
(6H, m, 3ꢁCCH2C), 2.02, 2.04, 2.07, 2.16 (12H, 4s, 4ꢁCH3CO), 2.49–
2.56 and 2.88–2.96 (4H, 2m, 2ꢁNCH2), 3.59 (1H, ddd, J¼10.0, 4.8
and 2.6 Hz, 5-H), 3.98 (1H, d, J¼8.9 Hz,1-H), 4.11 (1H, dd, J¼12.1 and
2.6 Hz, 6a-H), 4.23 (1H, dd, J¼12.1 and 4.8 Hz, 6b-H), 4.99 (1H, t,
J¼9.4 Hz, 4-H), 5.17 (1H, t, J¼9.3 Hz, 2-H) and 5.20 (1H, t, J¼8.5 Hz,
4.9. [N-[(6-O-Trityl)-2,3,4-tri-O-acetyl]-b-D-glucopyranosyl]-
N-methyl-3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-
ylidene)-1-propanamine (22)
3-H); 13C NMR:
d
(CDCl3) 21.0, 21.1 (ꢁ2), 21.2, 24.9, 26.7, 49.4, 62.8,
67.9, 69.4, 73.4, 74.3, 94.9, 169.9, 170.0, 170.7 and 171.0; m/z (ES þve
mode) 438 (MNaþ, 100%).
To a solution of 21 (1.5 mmol) in pyridine (15 mL) at 0 ꢀC under
nitrogen was added acetic anhydride (9 mmol). The reaction was
allowed to reach room temperature on addition of the acetic anhy-
dride and left stirring for 4 h. The reaction was basified using satd
NaHCO3 until pH 7 was reached, then the solution was diluted with
DCM (60 mL) and the organic layer was separated. The aqueous layer
was then extracted with DCM (3ꢁ50 mL) and the combined DCM
layers were washed with water (100 mL), brine (100 mL) and dried
over Na2SO4. After evaporation, column chromatography was carried
out using 50:50 ether/hexane to afford the product 22 (79%) as an
amorphous foam. Found: m/z, 794.3710. C50H52NO8 (MHþ) requires
4.6. [N-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-N-
methyl]piperidinium trifluoromethanesulfonate (17)
To a solution of 16 (0.100 g, 0.24 mmol) in DCM (2 mL) under
nitrogen was added MeOTf (0.48 mmol). The reaction was left
stirring for 4 h at room temperature, and then the DCM was re-
moved in vacuo. Column chromatography was carried out using
100% EtOAc, then 50:50 ethanol/DCM. The ethanol/DCM fractions
were combined and solvent removed to give 17 in 62% yield as
a foam. Found: m/z, 430.2064. C20H32NO9 requires m/z, 430.2077;
m/z, 794.3693; 1H NMR:
d (CD3CN) 1.73, 1.77 and 1.95 (9H, 3s,
1H NMR:
d
(CDCl3) 1.70–1.80 (3H, m, CCH2C), 1.98, 2.03, 2.05 and
3ꢁCH3CO), 2.39 (5H, m, ]CHCH2þNCH3), 2.75–3.20 (6H, m,
ArCH2CH2ArþNCH2CH2), 3.25–3.60 (3H, m, 2ꢁ6-Hþ5-H), 4.15–4.35
(1H, br d, 1-H), 5.10–5.25 (3H, br m, 2-Hþ3-Hþ4-H), 5.87 (1H, t,
]CHCH2), 7.04–7.06 (1H, m, ArH), 7.09–7.17 (3H, m, ArH), 7.22–7.34
(13H, m, ArH) and 7.42–7.51 (6H, m, ArH); the 1H NMR spectrum
showed very broad signals and meaningful coupling constants can-
2.12 (12H, 4s, 4ꢁCH3CO), 2.00–2.10 (3H, m, CCH2C), 3.30 (3H, s,
CH3Nþ), 3.60–3.95 (4H, m, 2ꢁCH2Nþ), 4.27 (1H, dd, J¼12.6 and
5.9 Hz, 6a-H), 4.36–4.44 (2H, m, 6b-Hþ5-H), 5.23 (1H, t, J¼9.7 Hz,
4-H), 5.49 (1H, dd, J¼9.4 and 8.3 Hz, 3-H), 5.69–5.78 (2H, m,1-Hþ2-
H); 13C NMR:
d
(CDCl3) 20.7, 20.9, 21.0 (ꢁ2), 21.3, 21.8, 61.8, 62.2,
62.6, 68.4, 68.9, 74.6, 76.5, 90.9, 122.5 (CF3, q, J¼320 Hz), 170.5 (ꢁ2),
not be quoted; 13C NMR:
d
(CD3CN) 19.4 (ꢁ2), 19.6, 22.0, 27.4, 31.0,
170.6 and 171.3; m/z (ES þve mode) 430 (cation Mþ, 100%).
31.3, 33.0, 33.4, 61.6, 67.9, 68.1, 73.4, 73.6, 85.7, 92.2, 125.3, 125.7,
126.7, 127.1, 127.5, 127.7, 128.1, 128.2, 129.2, 129.7, 136.7, 139.1, 139.8,
141.0, 142.9, 143.6, 168.6, 169.0 and 169.6; m/z (ES þve mode) 794
(MHþ, 100%).
4.7. [N-(b-D-Glucopyranosyl)-N-methyl]piperidinium
trifluoromethanesulfonate (18)
To a solution of 17 (0.532 g, 0.92 mmol)inMeOH(6 mL)wasadded
NaOMe (0.046 mmol). The reaction was left stirring at room tem-
perature for 5 h, then quenched with Amberlite Hþ resin
(0.046 mmol) to reach pH 7. The resin was filtered off and washed
withmethanol, and then thesolventwas removed invacuotogive the
product 18 in quantitative yield as a non-crystalline foam. Found: m/z,
4.10. [N-[2,3,4-Tri-O-acetyl]-b-D-glucopyranosyl]-N,N-
dimethyl-3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-
ylidene)-1-propanammonium trifluoromethanesulfonate (23)
To a solution of 22 (0.38 mmol) in DCM (8 mL) under nitrogen
was added MeOTf (0.76 mmol). The reaction was left stirring at
20 ꢀC for 17 h. The DCM was removed in vacuo and column chro-
matography was carried out using 100% EtOAc, and then 20% EtOH/
DCM to afford the product 23 (59%) as an amorphous foam. Found:
m/z, 566.2740. C32H40NO8 requires m/z, 566.2754; nmax (diamond)
262.1661. C12H24NO5 requires m/z, 262.1654; 1H NMR:
d [(CD3)2CO]
1.69–1.78,1.91–2.03, 2.05–2.12 (6H, m, 3ꢁCCH2C), 3.27 (3H, s, CH3Nþ),
3.48 (1H, t, J¼9.5 Hz, 4-H), 3.45–3.75 (2H, m, CH2Nþ), 3.65–3.75 (2H,
m, 2ꢁ6-H), 3.67 (1H, t, J¼9.3 Hz, 3-H), 3.87–3.98 (2H, m, CH2Nþ), 3.90
(1H, t, J¼8.8 Hz, 2-H), 4.10–4.20(1H, m, 5-H) and 5.00 (1H, d, J¼8.8 Hz,
1-H); 13C NMR:
d
[(CD3)2CO] 20.7, 20.8, 22.0, 45.5, 61.1, 61.8, 61.9, 70.2,
cmꢂ1 3347 (br s), 1751, 1604, 1520 and 1452; 1H NMR:
d (CD3CN,
71.6, 78.7, 81.7, 93.5, 119.9 (CF3, q, J¼320 Hz); only the central two
peaks of the CF3 quartet can be assigned confidently as this is a weak
spectrum; m/z (ES þve mode) 262 (cation Mþ, 100%).
343 K) 2.01, 2.03 and 2.09 (9H, 3d, 3ꢁCH3CO; fluxional effects), 2.64
(2H, m, ]CHCH2), 3.02, 3.04 (6H, 2d, 2ꢁCH3Nþ), 2.95–3.30 (4H, br
m, ArCH2CH2Ar), 3.30–3.45 (1H, br m, one NþCH2), 3.50–3.70 (4H,
br m, 2ꢁ6-Hþ5-Hþone NþCH2), 4.86 (1H, approx. d, J¼6.5 Hz, 1-H),
5.08 (1H, approx. t, J¼9 Hz, 4-H), 5.26 (1H, approx. t, J¼7.8 Hz, 3-H),
5.41 (1H, dd, J¼9.2 and 7.5 Hz, 2-H), 5.79 (1H, t, J¼6.4 Hz, ]CHCH2)
4.8. [N-(6-O-Trityl)-b-D-glucopyranosyl]-N-methyl-3-(10,11-
dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-
propanamine (21)
and 7.05–7.45 (8H, m, ArH); 13C NMR:
d (CD3CN) 19.5, 19.6, 19.8,
22.5, 31.2, 32.9, 48.3, 59.2, 63.6, 66.3, 67.0, 72.8, 77.5, 91.0, 120.5
(CF3, q, J¼310 Hz), 122.8, 125.9, 127.1, 127.4, 127.7, 128.1, 130.0, 136.9,
138.6, 139.1, 169.3, 169.6 and 169.8; only the central two peaks of
To a solution of 6-O-trityl glucose 19 (2.83 mmol) in DCM
(15 mL) under nitrogen was added nortriptyline 20 (2.83 mmol).